Therefore, a decrease in tissue ACE activity (either due to constitutive intrinsic mutations or ACE inhibitor treatment) could be associated with Alzheimer’s disease (AD) pathogenesis. The gene discussed is ACE; the disease is early-onset autosomal dominant Alzheimer disease.